Sanara MedTech (SMTI) Free Cash Flow (2010 - 2026)

Sanara MedTech (SMTI) has 16 years of Free Cash Flow data on file, last reported at -$2.5 million in Q1 2026.

• Quarterly Free Cash Flow rose 32.58% year-over-year to -$2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (up 247.24% YoY) and the FY2025 annual result came in at $2.2 million, up 1041.06% from the prior year.
• Free Cash Flow eased to -$2.5 million in Q1 2026, from $3.9 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $3.9 million in Q4 2025 to a low of -$3.7 million in Q1 2025.
• A 5-year average of -$575912.9 and a median of -$1.2 million in 2022 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2022 — Free Cash Flow slumped 235.03% — and 2025, when it surged 349.24%.
• Tracing SMTI's Free Cash Flow over 5 years: stood at -$698380.0 in 2022, then fell by 29.27% to -$902808.0 in 2023, then jumped by 195.24% to $859875.0 in 2024, then surged by 349.24% to $3.9 million in 2025, then tumbled by 164.96% to -$2.5 million in 2026.
• The last three Free Cash Flow figures came in at -$2.5 million (Q1 2026), $3.9 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.